中駿商管(00606.HK)2021年純利大增約80.2%至2.806億元 末期息5港仙
格隆匯3月30日丨中駿商管(00606.HK)公吿,截至2021年12月31日止年度,公司收益大幅上升約52.7%至約人民幣12.301億元,毛利率增長約2.9百分點至約47.2%,母公司擁有人應占溢利大幅增加約80.2%至約人民幣2.806億元,母公司擁有人應占核心溢利(不包括一次性的發行股份費用)大幅增加約84.4%至約人民幣3.017億元,董事會建議宣派末期股息每股普通股港元5分。
期間總簽約建築面積及在管建築面積分別增長約25.9%及37.9%至約4,610萬平方米及2,240萬平方米。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.